Hello, Guest
Login
Sign Up
 
 

PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Dendreon Corp, Parkervision, and Aeterna Zentaris

www.PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States with the potential of breaking out.

 
 
Repost This

Beverly Hills, CA -- (SBWIRE) -- 01/12/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: DNDN, PRKR, and AEZS

The market saw gains this week but the S&P 500 fell a little short of its highest level seen in 5 years from last Thursday. The index gained 5 points this week and closed at 1,472.05. The Dow Jones rose 53 points for the week and the Nasdaq composite index rose 24 points for the week.

1. Dendreon Corp. (Nasdaq: DNDN) - Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer.

2. Parkervision (Nasdaq: PRKR) - ParkerVision, Inc. operates two segments - the Video Products Division and the Wireless Technology Division.

3. Aeterna Zentaris (Nasdaq: AEZS) - AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology.

Pennystocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure: Pennystocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.